Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphomaBlanca Xicoy, Josep‐María Ribera, Pilar Miralles et al.|Haematologica|2007Cited by 123
Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient CharacteristicsJuan Berenguer, Carmen Quereda, Leire Pérez‐Latorre et al.|Open Forum Infectious Diseases|2016Cited by 42
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015José Antonio Iribarren, Miguel Ángel von Wichmann, Rafael Rubio et al.|Enfermedades Infecciosas y Microbiología Clínica|2016Cited by 18
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015José Antonio Iribarren, Miguel Ángel von Wichmann, Rafael Rubio et al.|Enfermedades Infecciosas y Microbiología Clínica|2016Cited by 17
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimensDaniel Podzamczer, Antonio Rivero, Arkaitz Imaz et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 10